Search research articles
Contact Us
Filters
Showing results (1-10 of 184) with videos related to
Page
of 19
Sort By:
Antiviral Chemistry & Chemotherapy
|
November 26, 2010
Nanoparticulate delivery systems for antiviral drugs
David Lembo, Roberta Cavalli
Expert Opinion on Drug Delivery
|
May 12, 2015
Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations
Federica Leone, Roberta Cavalli
Current Pharmaceutical Biotechnology
|
October 31, 2015
Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs
Dominique Duchene, Roberta Cavalli, Ruxandra Gref
Nanomedicine (London, England)
|
January 30, 2018
Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives
David Lembo, Francesco Trotta, Roberta Cavalli
Beilstein Journal of Organic Chemistry
|
December 18, 2012
Cyclodextrin-based nanosponges as drug carriers
Francesco Trotta, Marco Zanetti, Roberta Cavalli
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
January 23, 2016
Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development
Shankar Swaminathan, Roberta Cavalli, Francesco Trotta
Expert Opinion on Drug Delivery
|
February 4, 2025
What are the future applications of chitosan nanobubbles in drug delivery?
Monica Argenziano, Rita Spagnolo, Roberta Cavalli
International Journal of Pharmaceutics
|
September 7, 2013
Micro- and nanobubbles: a versatile non-viral platform for gene delivery
Roberta Cavalli, Agnese Bisazza, David Lembo
Nanomedicine (London, England)
|
February 21, 2020
Nanosponges for combination drug therapy: state-of-the-art and future directions
Maria Tannous, Francesco Trotta, Roberta Cavalli
Therapeutic Delivery
|
January 16, 2016
Nanobubbles: a promising efficient tool for therapeutic delivery
Roberta Cavalli, Marco Soster, Monica Argenziano
Page
of 19
Search research articles
Search
Showing results (1-10 of 184) with videos related to
Sort By:
Page
of 19
Antiviral Chemistry & Chemotherapy
|
November 26, 2010
Nanoparticulate delivery systems for antiviral drugs
David Lembo, Roberta Cavalli
Expert Opinion on Drug Delivery
|
May 12, 2015
Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations
Federica Leone, Roberta Cavalli
Current Pharmaceutical Biotechnology
|
October 31, 2015
Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs
Dominique Duchene, Roberta Cavalli, Ruxandra Gref
Nanomedicine (London, England)
|
January 30, 2018
Cyclodextrin-based nanosponges as vehicles for antiviral drugs: challenges and perspectives
David Lembo, Francesco Trotta, Roberta Cavalli
Beilstein Journal of Organic Chemistry
|
December 18, 2012
Cyclodextrin-based nanosponges as drug carriers
Francesco Trotta, Marco Zanetti, Roberta Cavalli
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|
January 23, 2016
Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development
Shankar Swaminathan, Roberta Cavalli, Francesco Trotta
Expert Opinion on Drug Delivery
|
February 4, 2025
What are the future applications of chitosan nanobubbles in drug delivery?
Monica Argenziano, Rita Spagnolo, Roberta Cavalli
International Journal of Pharmaceutics
|
September 7, 2013
Micro- and nanobubbles: a versatile non-viral platform for gene delivery
Roberta Cavalli, Agnese Bisazza, David Lembo
Nanomedicine (London, England)
|
February 21, 2020
Nanosponges for combination drug therapy: state-of-the-art and future directions
Maria Tannous, Francesco Trotta, Roberta Cavalli
Therapeutic Delivery
|
January 16, 2016
Nanobubbles: a promising efficient tool for therapeutic delivery
Roberta Cavalli, Marco Soster, Monica Argenziano
Page
of 19